Skip to main content
Top
Published in: Drugs & Aging 7/2018

01-07-2018 | Original Research Article

Statin Use is Not Associated with Future Long-Term Care Admission: Extended Follow-Up of Two Randomised Controlled Trials

Authors: Jennifer K. Burton, Richard Papworth, Caroline Haig, Colin McCowan, Ian Ford, David J. Stott, Terence J. Quinn

Published in: Drugs & Aging | Issue 7/2018

Login to get access

Abstract

Background

Statins have been associated with later life, long-term care admission in observational studies. However, by preventing vascular events, statins may also prevent or delay admission. We wished to determine statin and long-term care admission associations in a randomised controlled trial context, and describe associations between long-term care admission and other clinical and demographic factors.

Methods

We used extended follow-up of two randomised trial populations, using national data to assign the long-term care admission outcome, and included individuals screened or recruited to two large randomised trials of pravastatin 40 mg daily—the West of Scotland Coronary Prevention Study (WOSCOPS) and the pravastatin in elderly individuals at risk of vascular disease (PROSPER) study. We described univariable and multivariable analyses of potential predictors of long-term care admission with corresponding survival curves of incident long-term care admission and analyses adjusted for competing risk.

Results

In total 11,015 (10%) of the trial participants were admitted to long-term care. There was no difference between participants in the statin or placebo arms of either trial in regard to admissions to long-term care. On multivariable analyses, independent associations with incident long-term care admission in the PROSPER trial were age (hazard ratio [HR] 1.06 per year, 95% confidence interval [CI] 1.03–1.09) and male sex (HR 0.72, 95% CI 0.53–0.99). In the WOSCOPS, age (HR 1.12 per year, 95% CI 1.10–1.13) and increasing social deprivation (HR 1.05, 95% CI 1.03–1.08) were associated with incident long-term care admission.

Conclusion

We did not demonstrate an association between historical statin use and future long-term care admission. The strongest associations with incident long-term care admission were non-modifiable factors of age, sex and socioeconomic deprivation.
Literature
1.
go back to reference Ford I, Murray H, Packard CJ, et al. Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med. 2007;357(15):1477–86.CrossRef Ford I, Murray H, Packard CJ, et al. Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med. 2007;357(15):1477–86.CrossRef
2.
go back to reference Davies JT, Delfino SF, Feinberg CE, et al. Current and emerging uses of statins in clinical therapeutics: a review. Lipid Insights. 2016;9:13–29.CrossRef Davies JT, Delfino SF, Feinberg CE, et al. Current and emerging uses of statins in clinical therapeutics: a review. Lipid Insights. 2016;9:13–29.CrossRef
3.
go back to reference McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Syst Rev. 2016;(1):CD003160. McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Syst Rev. 2016;(1):CD003160.
4.
go back to reference Scott D, Blizzard L, Fell J, Jones G. Statin therapy, muscle function and falls risk in community-dwelling older adults. QJM. 2009;102(9):625–33.CrossRef Scott D, Blizzard L, Fell J, Jones G. Statin therapy, muscle function and falls risk in community-dwelling older adults. QJM. 2009;102(9):625–33.CrossRef
5.
go back to reference Salkeld G, Cameron ID, Cumming RG, et al. Quality of life related to fear of falling and hip fracture in older women: a time trade off study. BMJ. 2000;320:241–6.CrossRef Salkeld G, Cameron ID, Cumming RG, et al. Quality of life related to fear of falling and hip fracture in older women: a time trade off study. BMJ. 2000;320:241–6.CrossRef
6.
go back to reference Quinn TJ, McArthur K, Ellis G, Stott DJ. Functional assessment in older people. BMJ. 2011;343:d4681.CrossRef Quinn TJ, McArthur K, Ellis G, Stott DJ. Functional assessment in older people. BMJ. 2011;343:d4681.CrossRef
7.
go back to reference Rubin EB, Buehler AE, Halpern SD. States worse than death among hospitalized patients with serious illnesses. JAMA Intern Med. 2016;176:1557–9.CrossRef Rubin EB, Buehler AE, Halpern SD. States worse than death among hospitalized patients with serious illnesses. JAMA Intern Med. 2016;176:1557–9.CrossRef
8.
go back to reference Ribbe MW, Ljunggren G, Steel K, et al. Nursing homes in 10 nations: a comparison between countries and settings. Age Ageing. 1997;26(Suppl 2):3–12.CrossRef Ribbe MW, Ljunggren G, Steel K, et al. Nursing homes in 10 nations: a comparison between countries and settings. Age Ageing. 1997;26(Suppl 2):3–12.CrossRef
9.
go back to reference Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333(20):1301–7.CrossRef Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333(20):1301–7.CrossRef
10.
go back to reference Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360(9346):1623–30.CrossRef Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360(9346):1623–30.CrossRef
11.
go back to reference WOSCOPS Study Group. Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. Am J Cardiol. 1995;76:485–91.CrossRef WOSCOPS Study Group. Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. Am J Cardiol. 1995;76:485–91.CrossRef
12.
go back to reference Ford I, Blauw GJ, Murphy MB, et al. A prospective study of pravastatin in the elderly at risk (PROSPER) screening experience and baseline characteristics. Curr Control Trials Cardiovasc Med. 2002;3:8.CrossRef Ford I, Blauw GJ, Murphy MB, et al. A prospective study of pravastatin in the elderly at risk (PROSPER) screening experience and baseline characteristics. Curr Control Trials Cardiovasc Med. 2002;3:8.CrossRef
13.
go back to reference Ford I, Murray H, McCowan C, Packard CJ. Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy: 20-year follow-up of West of Scotland Coronary Prevention Study. Circulation. 2016;133(11):1073–80.CrossRef Ford I, Murray H, McCowan C, Packard CJ. Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy: 20-year follow-up of West of Scotland Coronary Prevention Study. Circulation. 2016;133(11):1073–80.CrossRef
14.
go back to reference The West of Scotland Coronary Prevention Study Group. A coronary primary prevention study of Scottish men aged 45–64 years: trial design. J Clin Epidemiol. 1992;45(8):849–60.CrossRef The West of Scotland Coronary Prevention Study Group. A coronary primary prevention study of Scottish men aged 45–64 years: trial design. J Clin Epidemiol. 1992;45(8):849–60.CrossRef
15.
go back to reference Shepherd J, Blauw GJ, Murphy MB, et al. The design of a prospective study of pravastatin in the elderly at risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol. 1999;84(10):1192–7.CrossRef Shepherd J, Blauw GJ, Murphy MB, et al. The design of a prospective study of pravastatin in the elderly at risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol. 1999;84(10):1192–7.CrossRef
16.
go back to reference Carstairs V, Morris R. Deprivation and health in Scotland. Health Bull (Edinb). 1990;48(4):162–75.PubMed Carstairs V, Morris R. Deprivation and health in Scotland. Health Bull (Edinb). 1990;48(4):162–75.PubMed
17.
go back to reference McLoone P, Boddy FA. Deprivation and mortality in Scotland, 1981 and 1991. BMJ. 1994;309(6967):1465–70.CrossRef McLoone P, Boddy FA. Deprivation and mortality in Scotland, 1981 and 1991. BMJ. 1994;309(6967):1465–70.CrossRef
18.
go back to reference Barry SJ, Dinnett E, Kean S, et al. Are routinely collected NHS administrative records suitable for endpoint identification in clinical trials? Evidence from the West of Scotland Coronary Prevention Study. PLoS One. 2013;8(9):e75379.CrossRef Barry SJ, Dinnett E, Kean S, et al. Are routinely collected NHS administrative records suitable for endpoint identification in clinical trials? Evidence from the West of Scotland Coronary Prevention Study. PLoS One. 2013;8(9):e75379.CrossRef
19.
go back to reference Gnjidic D, Le Couteur DG, Blyth FM, et al. Statin use and clinical outcomes in older men: a prospective population-based study. BMJ Open. 2013;3(3):e002333.CrossRef Gnjidic D, Le Couteur DG, Blyth FM, et al. Statin use and clinical outcomes in older men: a prospective population-based study. BMJ Open. 2013;3(3):e002333.CrossRef
20.
go back to reference Pruchno R, Hahn S, Wilson-Genderson M. Cigarette smokers, never-smokers, and transitions: implications for successful aging. Int J Aging Hum Dev. 2012;74(3):193–209.CrossRef Pruchno R, Hahn S, Wilson-Genderson M. Cigarette smokers, never-smokers, and transitions: implications for successful aging. Int J Aging Hum Dev. 2012;74(3):193–209.CrossRef
21.
go back to reference Harrison JK, Walesby KE, Hamilton L, et al. Predicting discharge to institutional long-term care following acute hospitalisation: a systematic review and meta-analysis. Age Ageing. 2017;46(4):547–58.CrossRef Harrison JK, Walesby KE, Hamilton L, et al. Predicting discharge to institutional long-term care following acute hospitalisation: a systematic review and meta-analysis. Age Ageing. 2017;46(4):547–58.CrossRef
22.
go back to reference Luppa M, Luck T, Weyerer S, et al. Prediction of institutionalization in the elderly. A systematic review. Age Ageing. 2010;39(1):31–8.CrossRef Luppa M, Luck T, Weyerer S, et al. Prediction of institutionalization in the elderly. A systematic review. Age Ageing. 2010;39(1):31–8.CrossRef
23.
go back to reference Doubal FN, Ali M, Batty GD, et al. Big data and data repurposing: using existing data to answer new questions in vascular dementia research. BMC Neurol. 2017;17(1):72.CrossRef Doubal FN, Ali M, Batty GD, et al. Big data and data repurposing: using existing data to answer new questions in vascular dementia research. BMC Neurol. 2017;17(1):72.CrossRef
24.
go back to reference Ruscica M, Macchi C, Pavanelo C, Corsini A, Sahebkar A, Sirtoni CR. Appropriateness of statin prescription in the ederly. Eur J Intern Med. 2018;50:33–40.CrossRef Ruscica M, Macchi C, Pavanelo C, Corsini A, Sahebkar A, Sirtoni CR. Appropriateness of statin prescription in the ederly. Eur J Intern Med. 2018;50:33–40.CrossRef
25.
go back to reference Murphy C, Bennett K, Fahey T, et al. Statin use in adults at high risk of cardiovascular disease mortality: cross-sectional analysis of baseline data from The Irish Longitudinal Study on Ageing (TILDA). BMJ Open. 2015;5(7):e008017.CrossRef Murphy C, Bennett K, Fahey T, et al. Statin use in adults at high risk of cardiovascular disease mortality: cross-sectional analysis of baseline data from The Irish Longitudinal Study on Ageing (TILDA). BMJ Open. 2015;5(7):e008017.CrossRef
26.
go back to reference Lloyd SM, Stott DJ, de Craen AJ, et al. Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS One. 2013;8(9):e72642.CrossRef Lloyd SM, Stott DJ, de Craen AJ, et al. Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS One. 2013;8(9):e72642.CrossRef
27.
go back to reference Sever PS, Chang CL, Gupta AK, et al. The Anglo-Scandinavian Cardiac Outcomes Trial: 11 year mortality follow-up of the lipid lowering arm in the UK. Eur Heart J. 2011;32:2525–32.CrossRef Sever PS, Chang CL, Gupta AK, et al. The Anglo-Scandinavian Cardiac Outcomes Trial: 11 year mortality follow-up of the lipid lowering arm in the UK. Eur Heart J. 2011;32:2525–32.CrossRef
28.
go back to reference Ridker PM, Lonn E, Paynter NP, Glynn R, Yusuf S. Primary prevention with statin therapy in the elderly. Circulaton. 2017;135:1979–81. Ridker PM, Lonn E, Paynter NP, Glynn R, Yusuf S. Primary prevention with statin therapy in the elderly. Circulaton. 2017;135:1979–81.
Metadata
Title
Statin Use is Not Associated with Future Long-Term Care Admission: Extended Follow-Up of Two Randomised Controlled Trials
Authors
Jennifer K. Burton
Richard Papworth
Caroline Haig
Colin McCowan
Ian Ford
David J. Stott
Terence J. Quinn
Publication date
01-07-2018
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 7/2018
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-018-0560-4

Other articles of this Issue 7/2018

Drugs & Aging 7/2018 Go to the issue